Fierce Biotec
Fierce Biotech is your source for the latest news, analysis and data in the world of biotech and pharma R&D.
-
Edgewise's stock jumps 50% on the back of safety data for potential heart disease rival to Camzyos
-
Aligos' MASH prospect slashes liver fat in phase 2, but stock drops anyway
-
Achilles drops cell therapy program, braces for layoffs after missing 'commercial viability' goals
-
Vanda receives FDA rejection, issues fiery response against ‘conclusory’ refusal
-
Basilea scores $268M BARDA funding deal to work on antifungals, antibiotics